1-5 of 5
Shaun R. McCann
Close
Sort by
Journal Articles

Mutation Mediated Resistance to the Tyrosine Kinase Inhibitors Imatinib, Dasatinib & Nilotinib in Philadelphia Positive Leukaemia

Lisa M O’ Connor, PhD, Stephen Langabeer, PhD, Shaun R. McCann, Eibhlin Conneally, MB, MRCP, MRCPath, PhD
Journal: Blood
Blood (2008) 112 (11): 4245.
https://doi.org/10.1182/blood.V112.11.4245.4245
Published: 2008
Journal Articles

BCR-ABL Kinase Domain Mutations & SNPs in Imatinib Resistant or Intolerant Chronic Myeloid Leukaemia Patients.

Lisa M. O’Connor, PhD, Stephen Langabeer, PhD, Shaun R. McCann, MD, Eibhlin Conneally, MD
Journal: Blood
Blood (2007) 110 (11): 2369.
https://doi.org/10.1182/blood.V110.11.2369.2369
Published: 2007
Journal Articles

Favourable Impact on Acute and Chronic Graft-Versus-Host Disease with Cyclophosphamide and In-Vivo Anti-CD52 Monoclonal Antibodies for Marrow Transplantation from HLA-Identical Sibling Donors for Acquired Aplastic Anaemia.

Vikas Gupta, Sarah E. Ball, Qi-long Yi, Deborah Sage, Shaun R. McCann, Mark Lawler, Miguel Ortin, Mylene Freires, Geoff Hale, Hermann Waldmann, Edward C. Gordon-Smith, Judith C.W. Marsh
Journal: Blood
Blood (2004) 104 (11): 3333.
https://doi.org/10.1182/blood.V104.11.3333.3333
Published: 2004
Journal Articles

Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML

Shaun R. McCann, Kathy Gately, Eibhlin Conneally, Mark Lawler
Journal: Blood
Blood (2003) 101 (3): 1200.
https://doi.org/10.1182/blood-2002-09-2932
Published: 2003
Journal Articles

Chimerism Following Donor Lymphocyte Infusion for Chronic Myeloid Leukemia

Nicola Gardiner, Shaun R. McCann, Joan O’Riordan, Mark Lawler
Journal: Blood
Blood (1999) 93 (8): 2748–2749.
https://doi.org/10.1182/blood.V93.8.2748
Published: 1999